StockData
biote Corp. logo

biote Corp. (BTMD) stock

BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$1.06+0.03 (+3.40%)

Close on Nov 13, 2026Market cap $38.26MP/E –Yield –

biote gross margin

Gross margin is gross profit as a percentage of revenue.

biote's gross margin for the twelve months ending Sep 30, 2026 was 67.5%. For fiscal 2025 it was 71.5%, against 70.5% the year before. The highest annual figure on record is 71.5% in fiscal 2025.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202571.5%+0.9
FY2024Dec 31, 202470.5%+1.7
FY2023Dec 31, 202368.8%+1.9
FY2022Dec 31, 202266.9%+1.9
FY2021Dec 31, 202165.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202667.7%−4.1
Q2 FY2026Jun 30, 202665.4%−6.2
Q1 FY2026Mar 31, 202668.9%−5.4
Q4 FY2025Dec 31, 202568.0%−3.8
Q3 FY2025Sep 30, 202571.8%+1.5
Q2 FY2025Jun 30, 202571.6%+2.8
Q1 FY2025Mar 31, 202574.3%+3.0
Q4 FY2024Dec 31, 202471.8%+2.5
Q3 FY2024Sep 30, 202470.3%+1.4
Q2 FY2024Jun 30, 202468.8%+0.9
Q1 FY2024Mar 31, 202471.3%+2.2
Q4 FY2023Dec 31, 202369.4%+4.0
Q3 FY2023Sep 30, 202368.9%+0.7
Q2 FY2023Jun 30, 202367.9%+0.6
Q1 FY2023Mar 31, 202369.1%+2.1
Q4 FY2022Dec 31, 202265.3%+1.4
Q3 FY2022Sep 30, 202268.2%+2.8
Q2 FY2022Jun 30, 202267.3%+0.8
Q1 FY2022Mar 31, 202266.9%–
Q4 FY2021Dec 31, 202164.0%–
Q3 FY2021Sep 30, 202165.4%–
Q2 FY2021Jun 30, 202166.5%–

More biote figures

See a number that looks wrong?